Trastuzumab-emtansine (Kadcyla®) in adjuvant treatment of adult patients with HER-2 positive breast cancer in an early stage
Wijma S, Tran L
Record ID 32018001618
Dutch
Original Title:
Package advice trastuzumab-emtansine (Kadcyla®) in adjuvant treatment of adult patients with HER-2 positive breast cancer in an early stage
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2020/09/24/trastuzumab-emtansine-kadcyla-in-adjuvant-treatment-of-adult-patients-with-her-2-positive-breast-cancer-in-an-early-stage
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Breast Neoplasms
- Antineoplastic Agents, Immunological
- Ado-Trastuzumab Emtansine
- Trastuzumab
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.